Lung Dendritic Cell Accumulation Precedes Pulmonary Fibrosis In Mice With Targeted Type Ii Alveolar Epithelial Cell Injury: Role Of Plasminogen Activator Inhibitor-1

被引:0
|
作者
Osterholzer, J. J. [1 ,2 ]
Murdock, B. J. [1 ,2 ]
Subbotina, N. [1 ]
Sisson, T. H. [1 ]
机构
[1] Univ Michigan, Sch Med, Ann Arbor, MI USA
[2] VA Ann Arbor Hlth Syst, Ann Arbor, MI USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A3449
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Pulmonary Fibrosis Following Targeted Type Ii Alveolar Epithelial Cell Injury Requires The Somatomedin B Binding Function Of Plasminogen Activator Inhibitor-1 But Not Vitronectin
    Roussey, J. A.
    Subbotina, N.
    Dotson, M.
    Virk, A.
    Osterholzer, J. J.
    Sisson, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [2] The Somatomedin B Binding Function Of Plasminogen Activator Inhibitor-1 Promotes The Accumulation Of Exudate Macrophages And Worsens Pulmonary Fibrosis Following Targeted Type Ii Alveolar Epithelial Cell Injury
    Osterholzer, J. J.
    Murdock, B. J.
    Subbotina, N.
    Simon, R. H.
    Sisson, T. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [3] Divergent Regulation of Alveolar Type 2 Cell and Fibroblast Apoptosis by Plasminogen Activator Inhibitor 1 in Lung Fibrosis
    Jiang, Chunsun
    Liu, Gang
    Cai, Lu
    Deshane, Jessy
    Antony, Veena
    Thannickal, Victor J.
    Liu, Rui-Ming
    AMERICAN JOURNAL OF PATHOLOGY, 2021, 191 (07): : 1227 - 1239
  • [4] Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis
    Bergheim, I
    Guo, LP
    Davis, MA
    Duveau, I
    Arteel, GE
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (02): : 592 - 600
  • [5] Role of plasminogen activator inhibitor-1 and vitronectin in the response to arterial injury in mice
    Konstantinides, S
    Schafer, K
    Thinnes, T
    Loskutoff, DJ
    CIRCULATION, 1999, 100 (18) : 703 - 703
  • [6] Increased Expression Of Plasminogen Activator Inhibitor 1 Contributes To Alveolar Type Ii Cell Senescence In Ipf Lung
    Jiang, C.
    Liu, G.
    Ding, Q.
    Antony, V. B.
    Thannickal, V. J.
    Liu, R. -M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [7] Phosphodiesterase 4 inhibition reduces lung fibrosis following targeted type II alveolar epithelial cell injury
    Sisson, Thomas H.
    Christensen, Paul J.
    Muraki, Yo
    Dils, Anthony J.
    Chibucos, Lauren
    Subbotina, Natalya
    Tohyama, Kimio
    Horowitz, Jeffrey C.
    Matsuo, Takanori
    Bailie, Marc
    Nikam, Sham
    Hazama, Masatoshi
    PHYSIOLOGICAL REPORTS, 2018, 6 (12):
  • [8] The role of plasminogen activator inhibitor-1 as inhibitor of platelet and megakaryoblastic cell adhesion
    Wohn, KD
    Schmidt, T
    Kanse, SM
    Yutzy, B
    Germer, M
    Morgenstern, E
    Preissner, KT
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (04) : 901 - 908
  • [9] Targeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary Fibrosis
    Sisson, Thomas H.
    Mendez, Michael
    Choi, Karen
    Subbotina, Natalya
    Courey, Anthony
    Cunningham, Andrew
    Dave, Aditi
    Engelhardt, John F.
    Liu, Xiaoming
    White, Eric S.
    Thannickal, Victor J.
    Moore, Bethany B.
    Christensen, Paul J.
    Simon, Richard H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (03) : 254 - 263
  • [10] Urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitor-1 in small cell carcinoma of the lung and non-small cell carcinoma of the lung
    Wajima, T
    VonHoff, DD
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2264 - P2264